Objective: To investigate associations between single nucleotide polymorphisms (SNPs) rs2228314 and rs2267443 in the sterol regulatory element binding protein-2 gene (SREBP-2) and knee osteoarthritis (OA) susceptibility in a Chinese Han population. Methods: SREBP-2 rs2228314 and rs2267443 polymorphisms were genotyped in patients with knee OA and age-and sex-matched OA-free controls from a Chinese Han population. Results: A total of 402 patients with knee OA and 410 controls were enrolled in the study. GC and CC genotypes of rs2228314, and variant C, were associated with a significantly increased risk of knee OA. On stratification analysis, the association between the risk of OA and rs2228314 GC heterozygotes compared with GG homozygotes was stronger in females and those aged >65 years. In contrast, the GA and AA genotypes of rs2267443 were not significantly associated with the risk of knee OA, even after further stratification analysis according to age or sex. Conclusions: SREBP-2 rs2228314 G to C change and variant C genotype may contribute to knee OA risk in a Chinese Han population.
Introduction
Osteoarthritis (OA) is a complex degenerative joint disease characterized by late-onset degeneration of the articular cartilage, 1 which results in structural and functional failure of synovial joints; 2 in 2008 it was estimated to affect 27 million people in the USA. 3 Factors including genetic susceptibility, increased mechanical load, injury, inflammation of the joint, age and obesity have been shown to contribute to OA risk. [4] [5] [6] [7] Interestingly, there is evidence that OA is not only a degenerative joint disease, but is also a metabolic disease associated with deregulation of genes involved in lipid metabolism and cholesterol efflux. 8 Furthermore, proteomic analysis studies have revealed that many proteins involved in lipid metabolism are differentially expressed in osteoarthritic cartilage compared with normal cartilage. 9, 10 Sterol regulatory element binding proteins (SREBPs) are transcription factors that bind to the sterol regulatory element DNA sequence and regulate lipid metabolism. 11 Three isoforms have so far been identified: SREBP-1a, SREBP-1c and SREBP-2. [12] [13] [14] [15] It has been reported that single nucleotide polymorphisms (SNPs) in the genes encoding for SREBPs are associated with diseases related to metabolic syndrome, including type 2 diabetes, 16 hyperlipoproteinaemia 17 and hypercholesterolaemia. 18 SREBP-2, encoded by a separate gene on human chromosome 22, plays a central role in the maintenance of lipid homeostasis. 11 This protein is found in the membrane of endoplasmic reticulum and forms a complex with SREBP cleavage activating protein (SCAP). 19 When cholesterol is deficient in cells, SCAP will transport SREBP-2 from the endoplasmic reticulum to the Golgi complex. Here, the proteins are cleaved by site-1 and site-2 proteases and are maturated to a soluble transcription factor that stimulates the expression of their target genes.
These genes encode enzymes with important roles in the synthesis and uptake pathways of cholesterol and triglyceride. 20 The SNP rs2228314 in the SREBP-2 gene results in substitution of a glycine by an alanine at amino acid 595 (G595A) of the SREBP-2 protein; it has been shown to be associated with intima-media thickness (a marker of atherosclerosis) and total cholesterol levels in hypercholesterolaemic patients, and with elevated plasma lipid levels. 21, 22 A study in Greek patients reported a significant association between the SNP rs2228314 in SREBP-2 and the development of OA. 23 In addition, the GA genotype of the SNP rs2267443 in SREBP-2 has been shown to be significantly associated with the risk of avascular necrosis of the femoral head in Chinese Han 24 and Korean populations. 25 On the basis of these studies, possible correlations between the SNPs rs2228314 (position 42276742) and rs2267443 (position 42287454) in SREBP-2 and susceptibility to knee OA were investigated in a Chinese Han population. As the distance between these two SNPs is 10 713 nucleotides, it was not necessary to perform haplotype analysis.
Patients and methods Patients
In this hospital-based case-control study, consecutive Han Chinese patients diagnosed with knee arthritis between March 2007 and May 2012 at the Department of Orthopaedics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China, were evaluated for inclusion. Anteroposterior extendedview weightbearing radiographs of the affected knees were obtained. Radiographic features were assessed by two examiners blinded to the clinical information to give a global Kellgren-Lawrence (KL) score ranging between 0 and 4, as previously described. 26 Only patients with radiographic OA, defined as a KL score of !2, were included in the study. Other aetiologies of knee joint disease such as inflammatory arthritis (rheumatoid, polyarthritic or autoimmune disease), post-traumatic or postseptic arthritis, skeletal dysplasia or developmental dysplasia were excluded.
Age-(AE5 years) and sex-matched healthy volunteers were recruited from the same hospital during the same period. Selection criteria for the controls included no history of OA and a KL score <2 on radiographic examination. Age, sex, weight, height and body mass index (BMI) were recorded for all study participants.
Written informed consent was provided by all participants and the study protocol was approved by the Ethics Committee of the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Genotyping
Venous blood samples were obtained from all study participants using ethylenediamine tetra-acetic acid anticoagulant (20 g/l). Genomic DNA was extracted immediately from 200 ml of venous blood using a QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions and stored at À80 C until analysis. The SNPs rs2228314 and rs2267443 in SREBP-2 were genotyped using the TaqMan SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA). The polymerase chain reaction (PCR) was performed using 100 ng of genomic DNA, 0.2 mM of each primer, 0.1 mM of each probe, 200 mM of each deoxyribonucleotide, 3 mM MgCl 2 and 1 U Platinum Taq DNA polymerase. PCR amplification was carried out using the 7900HT Fast Real-Time PCR System (Applied Biosystems) according to the manufacturer's instructions, with an initial denaturation at 95 C for 2 min, followed by 40 cycles of denaturation at 95 C for 15 s and annealing at 65 C for 30 s. Data analyses were performed using ABI PRISM 7900 Sequence Detection System software version 2.3 (Applied Biosystems). Approximately 5% of the samples were randomly selected for repeated genotyping, for confirmation.
Statistical analyses
The Hardy-Weinberg equilibrium was tested using a goodness-of-fit 2 -test to compare observed and expected genotype frequencies in controls. Differences in the distributions of demographic characteristics and rs2228314 and rs2267443 genotypes between patients with OA and controls were evaluated using the Wilcoxon's test for analysis of age and the 2 -test for all other variances. Associations between the SREBP-2 variants and OA risk were estimated by calculating the odds ratios (ORs) and 95% confidence intervals (CIs) using both univariate and multivariate logistic regression analysis with adjustments for age, sex and BMI. Two-sided tests were used for statistical analyses and a P-value < 0.05 was considered to be statistically significant. All statistical analyses were performed using SPSS Õ version 16.0 (SPSS Inc., Chicago, IL, USA). The statistical power of the study as calculated using Power and Sample Size Calculation software version 3.0 (Department of Biostatistics, Vanderbilt University, Nashville, TN, USA) was 0.56.
Results
A total of 802 Chinese Han patients with knee arthritis were evaluated. Of these, 402 had radiographic knee OA and were included in the study. In addition, 410 ageand sex-matched healthy controls were recruited. There were no significant differences in demographic characteristics between the two groups ( Table 1) .
The observed genotype frequencies for the rs2228314 and rs2267443 polymorphisms in the controls agreed with that expected according to the Hardy-Weinberg principle (data not shown). The results of repeat genotyping of randomly selected samples were 100% concordant.
The genotype and allele distributions of the rs2228314 and rs2267443 polymorphisms in patients with knee OA and healthy controls are shown in Table 2 . The genotype distribution for rs2228314 was significantly different between the two groups (P < 0.001). After adjustment for age, sex and BMI, a significantly increased risk of knee OA was associated with the genotype GC of rs2228314 compared with the GG genotype. In addition, those bearing at least one C allele (GC þ CC) had a significantly increased risk of knee OA compared with those without the C allele (GG). However, the GA and AA genotypes of rs2267443 were not significantly associated with the risk of knee OA.
Stratification analysis was performed to evaluate the potential association of genetic variants of SREBP-2 rs2228314 with knee OA risk in subgroups based on demographic characteristics. When stratified by age, both young ( 65 years) and old (>65 years) patients showed significant differences in genotype frequencies compared with controls (P < 0.001) ( Table 3) . When the association between C allele carriers and the risk of OA was evaluated using logistic regression analysis, GC heterozygotes carried a 1.82-fold increased risk of OA compared with GG homozygotes in the young patients group (Table 3) . Similarly, in the old patients group, GC heterozygotes carried a 2.49-fold increased risk of OA compared with GG homozygotes (Table 3) . When stratified by sex, both male and female patients showed significant differences in genotype frequencies between patients with OA and controls (P < 0.01) ( Table 3 ). In addition, GC heterozygotes carried a 1.55and 2.46-fold increased risk of knee OA in males and females, respectively, compared with GG homozygotes (Table 3 ).
In contrast, logistic regression analysis of SREBP-2 rs2267443 genetic variants showed that the GA and AA genotypes were not significantly associated with knee OA susceptibility when stratified by age or sex (Table 4 ).
Discussion
In the present hospital-based case-control study, associations between the potentially functional SNPs rs2228314 and rs2267443 in SREBP-2 and the risk of knee OA were investigated in a Chinese Han population. The results showed that the SNP rs2228314 polymorphic GC genotype of SREBP-2 and variant C may contribute to the risk of knee OA, and that this risk was increased in older (i.e. >65 years of age) and female patients.
To the best of our knowledge, this is the first report linking SREBP-2 SNP rs2228314 with knee OA in a Chinese Han population. There has been much evidence linking OA pathogenesis and lipid metabolism, prompting many scientists to characterize OA as a metabolic disease. 10, [27] [28] [29] SREBPs are transcription factors regulating genes involved in lipid metabolism. The SREBP-2 rs2228314 SNP causes an amino acid change from glycine to alanine (G595A). Muller and Miserez 18 reported that a G595A substitution located in the COOH-terminal regulating region could affect the formation and stability of the SREBP-2/SCAP complex. The 595 A isoform has been shown to decrease the stability of the complex compared with the 595 G isoform, thus affecting the role of SCAP as a sensor of sterol depletion or excess. 18 In addition, SREBP-2 has been shown to be upregulated in osteoarthritic chondrocytes. 23 The SNP rs2228314 of SREBP-2 was first identified as a risk factor for OA in a cohort study in a Greek population. 23 However, there have been no previous studies of the association between the SREBP-2 rs2228314 SNP and the risk of OA in a Chinese Han population. Combined with the results of previous studies, the present study supports the suggestion that the SNP rs2228314 of SREBP-2 gene might be a risk factor for OA. In the present study, individuals carrying SREBP-2 rs2228314 GC þ CC or GC genotypes had a higher risk of knee OA than those carrying the GG genotype, suggesting that the rs2228314 C allele might be associated with the development of knee OA.
According to the stratification analysis undertaken in the present study, the association between the risk of knee OA and rs2228314 GC heterozygotes compared with GG homozygotes was stronger in female patients and those >65 years old. This is consistent with the increased incidence of knee OA reported in those >50 years of age and in females. 30 As OA is a complex and multifactorial disease, both gene-gene and gene-environment interactions may occur and a single genetic variant is unlikely to be sufficient to predict overall risk. Further research is therefore needed to elucidate the role of other functional SNPs of SREBP-2 and other related genes involved in similar biological pathways that may be involved in the aetiology of OA. Studies have shown a significant association between the GA genotype of the rs2267443 SNP of SREBP-2 and the risk of avascular necrosis of the femoral head in a Chinese Han 24 and Korean populations. 25 However, in the present study, the GA and AA genotypes of rs2267443 were not significantly associated with the risk of knee OA. In addition, further stratification analysis according to age or sex did not reveal any significant associations between knee OA susceptibility and rs2267443 genotypes.
The present study had a number of limitations. First, as a hospital-based study, it may be subject to inherent biases; however, the C allele frequency in the control subjects was similar to that in the haplotype map database, and the genotype distributions of the rs2228314 and rs2267443 polymorphisms in the controls conformed to the Hardy-Weinberg equilibrium, suggesting that the results did not suffer from selection bias. Secondly, the sample size was relatively modest, therefore the results should be confirmed in larger scale studies. Thirdly, only two SREBP-2 SNPs were investigated; SNPs at other loci may also be associated with susceptibility to OA.
In conclusion, the present study was the first to show that the genotype distribution of the SREBP-2 rs2228314 polymorphism was significantly different between patients with knee OA and healthy controls in a Chinese Han population. Larger population-based and in-depth molecular studies are required, to validate these current findings and to elucidate the functional roles of the rs2228314 polymorphism in the aetiology of OA.
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